The NF-κB signaling pathway, activated in most cancers including leukemias, regulates the transcription of NGAL [1] and the MAPK pathway may cooperate with NF-κB to up-regulate the expression of NGAL [1]. This evidence concerns the gene LCN2 and cancer.